DAVENPORT & Co LLC lessened its position in GSK plc (NYSE:GSK – Free Report) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,522 shares of the pharmaceutical company’s stock after selling 343 shares during the period. DAVENPORT & Co LLC’s holdings in […]